Market Briefing
Fav
Drag topics here to pin them
Daily Pulse
Weekly Pulse
IBKR
Sentiment
Misc
Insider Buying — US Stocks (as of 2026-07-30)
Source: SEC EDGAR Form 4 filings. Open-market purchases by executives and directors. Grouped by filing date; trade date shown with days-to-file lag. Sorted by transaction value.
Filed 2026-07-30
| Ticker | Company | Sector | Insider | Title | Trade Date | Shares | Price | Value | % From 52wk Low |
|---|---|---|---|---|---|---|---|---|---|
| ACI | Albertsons Companies, Inc. | Consumer Staples | MORRIS SUSAN | Chief Executive Officer | 2026-07-28 (+2d) | 20,277 | $11.46 | $232,273 | +11.1% |
| ACI | Albertsons Companies, Inc. | Consumer Staples | MORRIS SUSAN | Chief Executive Officer | 2026-07-28 (+2d) | 19,132 | $11.38 | $217,665 | +11.1% |
| NTRS | NORTHERN TRUST CORP | Financials | Moritz Robert Edward Jr. | maybe director | 2026-07-29 (+1d) | 255 | $179.57 | $45,790 | +49.1% |
Filed 2026-07-27
| Ticker | Company | Sector | Insider | Title | Trade Date | Shares | Price | Value | % From 52wk Low |
|---|---|---|---|---|---|---|---|---|---|
| MKC | MCCORMICK & CO INC | Consumer Discretionary | Conway Michael Aaron | maybe director | 2026-07-23 (+4d) | 1,100 | $50.21 | $55,227 | +17.0% |
This content is for informational purposes only and does not constitute financial, investment, or trading advice. Always consult a qualified financial professional before making any investment decisions.
Insider Buying — US Stocks (as of 2026-07-29)
Source: SEC EDGAR Form 4 filings. Open-market purchases by executives and directors. Grouped by filing date; trade date shown with days-to-file lag. Sorted by transaction value.
Filed 2026-07-27
| Ticker | Company | Sector | Insider | Title | Trade Date | Shares | Price | Value | % From 52wk Low |
|---|---|---|---|---|---|---|---|---|---|
| MKC | MCCORMICK & CO INC | Consumer Discretionary | Conway Michael Aaron | maybe director | 2026-07-23 (+4d) | 1,100 | $50.21 | $55,227 | +16.0% |
This content is for informational purposes only and does not constitute financial, investment, or trading advice. Always consult a qualified financial professional before making any investment decisions.
Insider Buying — US Stocks (as of 2026-07-28)
Source: SEC EDGAR Form 4 filings. Open-market purchases by executives and directors. Grouped by filing date; trade date shown with days-to-file lag. Sorted by transaction value.
Filed 2026-07-27
| Ticker | Company | Sector | Insider | Title | Trade Date | Shares | Price | Value | % From 52wk Low |
|---|---|---|---|---|---|---|---|---|---|
| MKC | MCCORMICK & CO INC | Consumer Discretionary | Conway Michael Aaron | maybe director | 2026-07-23 (+4d) | 1,100 | $50.21 | $55,227 | +13.9% |
Filed 2026-07-22
| Ticker | Company | Sector | Insider | Title | Trade Date | Shares | Price | Value | % From 52wk Low |
|---|---|---|---|---|---|---|---|---|---|
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +29.8% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +29.8% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +29.8% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +29.8% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +29.8% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +29.8% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +29.8% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +29.8% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +29.8% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +29.8% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +29.8% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +29.8% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +29.8% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +29.8% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +29.8% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +29.8% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +29.8% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +29.8% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +29.8% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +29.8% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +29.8% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +29.8% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +29.8% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +29.8% |
This content is for informational purposes only and does not constitute financial, investment, or trading advice. Always consult a qualified financial professional before making any investment decisions.
Insider Buying — US Stocks (as of 2026-07-27)
Source: SEC EDGAR Form 4 filings. Open-market purchases by executives and directors. Grouped by filing date; trade date shown with days-to-file lag. Sorted by transaction value.
Filed 2026-07-27
| Ticker | Company | Sector | Insider | Title | Trade Date | Shares | Price | Value | % From 52wk Low |
|---|---|---|---|---|---|---|---|---|---|
| MKC | MCCORMICK & CO INC | Consumer Discretionary | Conway Michael Aaron | maybe director | 2026-07-23 (+4d) | 1,100 | $50.21 | $55,227 | +nan% |
Filed 2026-07-22
| Ticker | Company | Sector | Insider | Title | Trade Date | Shares | Price | Value | % From 52wk Low |
|---|---|---|---|---|---|---|---|---|---|
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +nan% |
This content is for informational purposes only and does not constitute financial, investment, or trading advice. Always consult a qualified financial professional before making any investment decisions.
Insider Buying — US Stocks (as of 2026-07-26)
Source: SEC EDGAR Form 4 filings. Open-market purchases by executives and directors. Grouped by filing date; trade date shown with days-to-file lag. Sorted by transaction value.
Filed 2026-07-22
| Ticker | Company | Sector | Insider | Title | Trade Date | Shares | Price | Value | % From 52wk Low |
|---|---|---|---|---|---|---|---|---|---|
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +nan% |
Filed 2026-07-20
| Ticker | Company | Sector | Insider | Title | Trade Date | Shares | Price | Value | % From 52wk Low |
|---|---|---|---|---|---|---|---|---|---|
| GFS | GLOBALFOUNDRIES Inc. | Information Technology | Hogan Michael James | Chief Strategy Officer | 2026-07-15 (+5d) | 12 | $61.41 | $737 | +nan% |
This content is for informational purposes only and does not constitute financial, investment, or trading advice. Always consult a qualified financial professional before making any investment decisions.
Insider Buying — US Stocks (as of 2026-07-25)
Source: SEC EDGAR Form 4 filings. Open-market purchases by executives and directors. Grouped by filing date; trade date shown with days-to-file lag. Sorted by transaction value.
Filed 2026-07-22
| Ticker | Company | Sector | Insider | Title | Trade Date | Shares | Price | Value | % From 52wk Low |
|---|---|---|---|---|---|---|---|---|---|
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +nan% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +nan% |
Filed 2026-07-20
| Ticker | Company | Sector | Insider | Title | Trade Date | Shares | Price | Value | % From 52wk Low |
|---|---|---|---|---|---|---|---|---|---|
| GFS | GLOBALFOUNDRIES Inc. | Information Technology | Hogan Michael James | Chief Strategy Officer | 2026-07-15 (+5d) | 12 | $61.41 | $737 | +nan% |
This content is for informational purposes only and does not constitute financial, investment, or trading advice. Always consult a qualified financial professional before making any investment decisions.
Insider Buying — US Stocks (as of 2026-07-24)
Source: SEC EDGAR Form 4 filings. Open-market purchases by executives and directors. Grouped by filing date; trade date shown with days-to-file lag. Sorted by transaction value.
Filed 2026-07-22
| Ticker | Company | Sector | Insider | Title | Trade Date | Shares | Price | Value | % From 52wk Low |
|---|---|---|---|---|---|---|---|---|---|
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +33.9% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +33.9% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +33.9% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +33.9% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +33.9% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +33.9% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +33.9% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +33.9% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +33.9% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +33.9% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +33.9% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +33.9% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +33.9% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +33.9% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +33.9% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +33.9% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +33.9% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +33.9% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +33.9% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +33.9% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +33.9% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +33.9% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +33.9% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +33.9% |
Filed 2026-07-20
| Ticker | Company | Sector | Insider | Title | Trade Date | Shares | Price | Value | % From 52wk Low |
|---|---|---|---|---|---|---|---|---|---|
| GFS | GLOBALFOUNDRIES Inc. | Information Technology | Hogan Michael James | Chief Strategy Officer | 2026-07-15 (+5d) | 12 | $61.41 | $737 | +80.9% |
This content is for informational purposes only and does not constitute financial, investment, or trading advice. Always consult a qualified financial professional before making any investment decisions.
Insider Buying — US Stocks (as of 2026-07-23)
Source: SEC EDGAR Form 4 filings. Open-market purchases by executives and directors. Grouped by filing date; trade date shown with days-to-file lag. Sorted by transaction value.
Filed 2026-07-22
| Ticker | Company | Sector | Insider | Title | Trade Date | Shares | Price | Value | % From 52wk Low |
|---|---|---|---|---|---|---|---|---|---|
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +25.7% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +25.7% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +25.7% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +25.7% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +25.7% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +25.7% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +25.7% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +25.7% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +25.7% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +25.7% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +25.7% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +25.7% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +25.7% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +25.7% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +25.7% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +25.7% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +25.7% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +25.7% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +25.7% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +25.7% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +25.7% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +25.7% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +25.7% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +25.7% |
Filed 2026-07-20
| Ticker | Company | Sector | Insider | Title | Trade Date | Shares | Price | Value | % From 52wk Low |
|---|---|---|---|---|---|---|---|---|---|
| GFS | GLOBALFOUNDRIES Inc. | Information Technology | Hogan Michael James | Chief Strategy Officer | 2026-07-15 (+5d) | 12 | $61.41 | $737 | +85.9% |
Filed 2026-07-17
| Ticker | Company | Sector | Insider | Title | Trade Date | Shares | Price | Value | % From 52wk Low |
|---|---|---|---|---|---|---|---|---|---|
| ELV | Elevance Health, Inc. | Health Care | BOUDREAUX GAIL | President and CEO | 2026-07-17 (+0d) | 2,045 | $368.25 | $753,071 | +45.1% |
| ELV | Elevance Health, Inc. | Health Care | PERU RAMIRO G | maybe director | 2026-07-17 (+0d) | 1,000 | $366.05 | $366,050 | +45.1% |
| ELV | Elevance Health, Inc. | Health Care | BOUDREAUX GAIL | President and CEO | 2026-07-17 (+0d) | 680 | $366.41 | $249,159 | +45.1% |
This content is for informational purposes only and does not constitute financial, investment, or trading advice. Always consult a qualified financial professional before making any investment decisions.
Insider Buying — US Stocks (as of 2026-07-22)
Source: SEC EDGAR Form 4 filings. Open-market purchases by executives and directors. Grouped by filing date; trade date shown with days-to-file lag. Sorted by transaction value.
Filed 2026-07-22
| Ticker | Company | Sector | Insider | Title | Trade Date | Shares | Price | Value | % From 52wk Low |
|---|---|---|---|---|---|---|---|---|---|
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +22.6% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +22.6% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +22.6% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-20 (+2d) | 98,433 | $27.13 | $2,670,487 | +22.6% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +22.6% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +22.6% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +22.6% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-22 (+0d) | 47,250 | $29.77 | $1,406,632 | +22.6% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +22.6% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +22.6% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +22.6% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-21 (+1d) | 37,723 | $30.00 | $1,131,690 | +22.6% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +22.6% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +22.6% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +22.6% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-20 (+2d) | 32,987 | $27.72 | $914,400 | +22.6% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +22.6% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +22.6% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +22.6% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-21 (+1d) | 21,696 | $27.96 | $606,620 | +22.6% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Healthcare Fund LP | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +22.6% |
| PBLS | Parabilis Medicines, Inc. | Health Care | RA Capital Nexus Fund III, L.P. | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +22.6% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Kolchinsky Peter | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +22.6% |
| PBLS | Parabilis Medicines, Inc. | Health Care | Shah Rajeev M. | maybe director | 2026-07-21 (+1d) | 6,504 | $29.17 | $189,722 | +22.6% |
Filed 2026-07-20
| Ticker | Company | Sector | Insider | Title | Trade Date | Shares | Price | Value | % From 52wk Low |
|---|---|---|---|---|---|---|---|---|---|
| GFS | GLOBALFOUNDRIES Inc. | Information Technology | Hogan Michael James | Chief Strategy Officer | 2026-07-15 (+5d) | 12 | $61.41 | $737 | +88.8% |
Filed 2026-07-17
| Ticker | Company | Sector | Insider | Title | Trade Date | Shares | Price | Value | % From 52wk Low |
|---|---|---|---|---|---|---|---|---|---|
| ELV | Elevance Health, Inc. | Health Care | BOUDREAUX GAIL | President and CEO | 2026-07-17 (+0d) | 2,045 | $368.25 | $753,071 | +46.8% |
| ELV | Elevance Health, Inc. | Health Care | PERU RAMIRO G | maybe director | 2026-07-17 (+0d) | 1,000 | $366.05 | $366,050 | +46.8% |
| ELV | Elevance Health, Inc. | Health Care | BOUDREAUX GAIL | President and CEO | 2026-07-17 (+0d) | 680 | $366.41 | $249,159 | +46.8% |
Filed 2026-07-16
| Ticker | Company | Sector | Insider | Title | Trade Date | Shares | Price | Value | % From 52wk Low |
|---|---|---|---|---|---|---|---|---|---|
| FIS | Fidelity National Information Services, Inc. | Information Technology | Goldstein Jeffrey A | maybe director | 2026-07-15 (+1d) | 1,386 | $41.39 | $57,367 | +11.1% |
This content is for informational purposes only and does not constitute financial, investment, or trading advice. Always consult a qualified financial professional before making any investment decisions.
Insider Buying — US Stocks (as of 2026-07-21)
Source: SEC EDGAR Form 4 filings. Open-market purchases by executives and directors. Grouped by filing date; trade date shown with days-to-file lag. Sorted by transaction value.
Filed 2026-07-20
| Ticker | Company | Sector | Insider | Title | Trade Date | Shares | Price | Value | % From 52wk Low |
|---|---|---|---|---|---|---|---|---|---|
| GFS | GLOBALFOUNDRIES Inc. | Information Technology | Hogan Michael James | Chief Strategy Officer | 2026-07-15 (+5d) | 12 | $61.41 | $737 | +80.6% |
Filed 2026-07-17
| Ticker | Company | Sector | Insider | Title | Trade Date | Shares | Price | Value | % From 52wk Low |
|---|---|---|---|---|---|---|---|---|---|
| ELV | Elevance Health, Inc. | Health Care | BOUDREAUX GAIL | President and CEO | 2026-07-17 (+0d) | 2,045 | $368.25 | $753,071 | +42.6% |
| ELV | Elevance Health, Inc. | Health Care | PERU RAMIRO G | maybe director | 2026-07-17 (+0d) | 1,000 | $366.05 | $366,050 | +42.6% |
| ELV | Elevance Health, Inc. | Health Care | BOUDREAUX GAIL | President and CEO | 2026-07-17 (+0d) | 680 | $366.41 | $249,159 | +42.6% |
Filed 2026-07-16
| Ticker | Company | Sector | Insider | Title | Trade Date | Shares | Price | Value | % From 52wk Low |
|---|---|---|---|---|---|---|---|---|---|
| FIS | Fidelity National Information Services, Inc. | Information Technology | Goldstein Jeffrey A | maybe director | 2026-07-15 (+1d) | 1,386 | $41.39 | $57,367 | +13.0% |
This content is for informational purposes only and does not constitute financial, investment, or trading advice. Always consult a qualified financial professional before making any investment decisions.